NuVasive Announces Conference Call and Webcast of Third Quarter 2021 Results

Rhea-AI Summary

NuVasive, Inc. (NASDAQ: NUVA) will release its third quarter 2021 earnings results on November 9, 2021, after market close. A conference call will follow at 4:30 p.m. ET to discuss financial performance. Interested parties can join via dial-in or an online webcast, with replays available until November 16, 2021. NuVasive specializes in spine technology innovation, offering minimally invasive solutions with over $1 billion in net sales and serving more than 50 countries.

Positive

• Strong brand presence in spine technology with over $1 billion in net sales.
• Operates in more than 50 countries, indicating a broad market reach.

Negative

• Risks and uncertainties associated with forward-looking statements can affect financial projections.

SAN DIEGO, Oct. 25, 2021 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today the Company will release its third quarter 2021 earnings results on Tuesday, November 9, 2021, after the close of the market.

NuVasive will hold a conference call on Tuesday, November 9, 2021, at 4:30 p.m. ET / 1:30 p.m. PT to discuss the results of its financial performance for the third quarter of 2021. The dial-in numbers are 1-877-407-9039 for domestic callers and 1-201-689-8470 for international callers. A live webcast of the conference call and supplemental financial information of the Company's third quarter financial results will be available on the Investor Relations page of the Company's website at www.nuvasive.com.

After the live event, the webcast will remain available on NuVasive's website for 30 days. In addition, an audio replay of the call will be available until November 16, 2021. The replay dial-in numbers are 1-844-512-2921 for domestic callers and 1-412-317-6671 for international callers. Please use pin number: 13722935.

About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine technology innovation, with a mission to transform surgery, advance care, and change lives. The Company's less-invasive, procedurally integrated surgical solutions are designed to deliver reproducible and clinically proven outcomes. The Company's comprehensive procedural portfolio includes surgical access instruments, spinal implants, fixation systems, biologics, software for surgical planning, navigation and imaging solutions, magnetically adjustable implant systems for spine and orthopedics, and intraoperative neuromonitoring technology and service offerings. With more than $1 billion in net sales, NuVasive has approximately 2,700 employees and operates in more than 50 countries serving surgeons, hospitals, and patients. For more information, please visit www.nuvasive.com. 

Forward-Looking Statements
NuVasive cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties which contribute to the uncertain nature of these statements include, but are not limited to, the risk that NuVasive's net sales or earnings projections may turn out to be inaccurate because of the preliminary nature of the forecasts; the risk of further adjustment to financial results or future financial expectations; unanticipated difficulty in selling products, generating net sales or producing expected profitability; and those other risks and uncertainties more fully described in NuVasive's news releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvasive-announces-conference-call-and-webcast-of-third-quarter-2021-results-301407073.html

SOURCE NuVasive, Inc.

FAQ

When will NuVasive release its third quarter 2021 earnings results?

NuVasive will release its third quarter 2021 earnings results on November 9, 2021, after market close.

What is NuVasive's stock symbol?

NuVasive's stock symbol is NUVA.

What time will NuVasive's conference call be held regarding the Q3 results?

The conference call will be held at 4:30 p.m. ET on November 9, 2021.

How can I access the webcast for NuVasive's conference call?

The webcast can be accessed on NuVasive's Investor Relations page on their website.

What precautions does NuVasive mention regarding forward-looking statements?

NuVasive mentions risks and uncertainties that could cause actual results to differ from forecasts.